NCT05634577 2025-06-19A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical CarcinomaM.D. Anderson Cancer CenterPhase 2 Terminated3 enrolled 7 charts
NCT00003453 2018-05-09Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland CancerBurzynski Research InstitutePhase 2 Terminated6 enrolled 6 charts
NCT00778817 2014-04-29IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by SurgeryNational Cancer Institute (NCI)Phase 2 Terminated20 enrolled 17 charts